Living Cell Technologies Limited at the AGM held on November 7, 2019, approved the appointment of Dr. Andrew Kelly to the board of company as a non-executive director, effective immediately. Dr. Kelly has an extensive background in research, commercialization and investment. In 2005 he co-founded BioPacificVentures, the first specialist venture fund in New Zealand and Australia to focus across the life sciences. In 2014 he broadened the business model to create BioPacific Partners, partnering with some of the largest global companies to invest and engage with local innovation. Dr. Kelly spent the early part of his career in life sciences research and development in Australia and Canada and then led research institutes in Australia and New Zealand. He later led product development and then early stage investment at AgResearch. In this role he built deep engagement with the global investor community. He has held a dozen board roles over the last 22 years all in businesses involved in life science innovation. Dr. Kelly has strong networks across New Zealand and Australia and globally.